Donovan Jenny, Mills Nicola, Smith Monica, Brindle Lucy, Jacoby Ann, Peters Tim, Frankel Stephen, Neal David, Hamdy Freddie
Department of Social Medicine, University of Bristol, Bristol BS8 2PR, UK.
BMJ. 2002 Oct 5;325(7367):766-70. doi: 10.1136/bmj.325.7367.766.
Recruitment to randomised trials is often difficult, and many important trials are not mounted because recruitment is thought to be "impossible."
Controversial ProtecT (prostate testing for cancer and treatment) trial embedded within qualitative research.
Screening for prostate cancer is hotly debated, and evidence from trials about the effectiveness of treatments (surgery, radiotherapy, and monitoring) is lacking. Mounting a treatment trial is controversial because of past failures and concerns that differences in complications of treatment but not survival make randomisation unacceptable to patients and clinicians, particularly for a trial including monitoring.
In-depth interviews explored interpretation of study information. Audiotape recordings of recruitment appointments enabled scrutiny of content and presentation of study information by recruiters. Initial qualitative findings showed that recruiters had difficulty discussing equipoise and presenting treatments equally; they unknowingly used terminology that was misinterpreted by participants. Findings were used to determine changes to content and presentation of information.
Changes to the order of presenting treatments encouraged emphasis on equivalence, misinterpreted terms were avoided, the non-radical arm was redefined, and randomisation and clinical equipoise were presented more convincingly. The randomisation rate increased from 40% to 70%, all treatments became acceptable, and the three arm trial became the preferred design.
Changes to information and presentation resulted in efficient recruitment acceptable to patients and clinicians. Embedding this controversial trial within qualitative research improved recruitment. Such methods probably have wider applicability and may enable even the most difficult evaluative questions to be tackled.
随机试验的受试者招募往往困难重重,许多重要试验因被认为“无法”招募受试者而未能开展。
在定性研究中嵌入有争议的ProtecT(前列腺癌检测与治疗)试验。
前列腺癌筛查备受争议,且缺乏关于治疗(手术、放疗和监测)有效性的试验证据。开展一项治疗试验存在争议,原因在于过去的失败案例以及人们担心治疗并发症的差异而非生存率差异会使患者和临床医生难以接受随机分组,尤其是对于一项包含监测的试验。
通过深入访谈探讨对研究信息的解读。招募预约的录音使得能够仔细审查招募人员对研究信息的表述内容。初步的定性研究结果表明,招募人员在讨论均衡性以及平等呈现治疗方案方面存在困难;他们在不知不觉中使用了会被参与者误解的术语。研究结果被用于确定信息内容和呈现方式的改变。
改变治疗方案的呈现顺序有助于强调等效性,避免使用被误解的术语,重新定义非根治性治疗组,并更有说服力地呈现随机分组和临床均衡性。随机分组率从40%提高到70%,所有治疗方案都变得可接受,三臂试验成为首选设计。
信息和呈现方式的改变带来了患者和临床医生都能接受的高效招募。将这项有争议的试验嵌入定性研究提高了招募效率。此类方法可能具有更广泛的适用性,甚至可能使最具挑战性的评估问题也能得到解决。